Cover Image

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?

<p>Abstract</p> <p>Background</p> <p>To evaluate medicine prices, availability and affordability in Brazil, considering the differences across three types of medicines (originator brands, generics and similar medicines) and different types of facilities (private pharmac...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bertoldi Andréa (Author), Helfer Ana (Author), Camargo Aline L (Author), Tavares Noêmia U L (Author), Kanavos Panos (Author)
Format:	Book
Published:	BMC, 2012-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Vaccine manufacturing is essential to ensure access
by: Laura A. Palomares
Published: (2022)

Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration
by: Bregtje W. Kamphuis, et al.
Published: (2021)

Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
by: Olina Efthymiadou, et al.
Published: (2022)

Is the pharmaceutical industry improving with regard to access to essential medicines?
by: Hans V Hogerzeil, et al.
Published: (2014)

Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP
by: Vandoros Sotiris, et al.
Published: (2009)

Expensive medicines: ensuring objective appraisal and equitable access
by: Suzanne R Hill, et al.

Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
by: Sabine Vogler, et al.
Published: (2024)

Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
by: Mackenzie Mills, et al.
Published: (2023)

Ensuring scientific rigor: essential recommendations on how to identify prior evidence in medicine
by: Israel Júnior Borges do Nascimento, et al.
Published: (2024)

Ensuring access to essential health products: Lessons from Colombia's leishmaniasis control and elimination initiative.
by: Carol Vlassoff, et al.
Published: (2023)

Ensuring access to essential health products: Lessons from Colombia's leishmaniasis control and elimination initiative
by: Carol Vlassoff, et al.
Published: (2023)

Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review
by: Mirza AH, et al.
Published: (2023)

Pharmaceutical services in primary health care: interfederative agreement in the development of pharmaceutical policies in the Brazilian Unified Health System (SUS)
by: Karen Sarmento Costa, et al.
Published: (2017)

Monitoring Cardiovascular Medicine Prices as a Tool for Analyzing the Effectiveness of Government Intervetions to Ensure Access to Medicines at the Regional Level
by: C. M. Razzakova, et al.
Published: (2020)

A Sociotechnical Approach to Analyze Pharmaceutical Policy and Services Management in Primary Health Care in a Brazilian Municipality
by: Noemia Liege Maria da Bernardo, et al.
Published: (2021)

Intraosseous access as a modern method of fast ensuring the access to the cardiovascular system in conditions of emergency medicine
by: Rafał Czyż, et al.
Published: (2017)

Intraosseous access as a modern method of fast ensuring the access to the cardiovascular system in conditions of emergency medicine
by: Rafał Czyż, et al.
Published: (2017)

Access and use of WHO essential medicines in Italy
by: Alessandro Petrella, et al.
Published: (2023)

An analysis of the essential medicines policy in primary care: Findings from MedMinas project
by: Tatiana Chama Borges Luz, et al.
Published: (2022)

Ensuring scientific rigour: essential recommendations on how to identify prior evidence in medicine-author's response
by: João Sérgio Fonseca Guimarães, et al.
Published: (2024)

Barriers to access to medicines for non-communicable diseases for patients using the Brazilian Unified Health System (SUS)
by: Samara Ramalho Matta, et al.
Published: (2021)

Access to essential medicines in national constitutions
by: SK Perehudoff, et al.
Published: (2010)

University Efforts for Quality to Ensure Epistemological Access
by: Irfana Omar, et al.
Published: (2019)

UN MILLENNIUM DEVELOPMENT GOALS INDICATORS ON PROBLEMS OF ACCESS TO ESSENTIAL MEDICINES AND ENHANCEMENT OF LOCAL PHARMACEUTICAL PRODUCER IN DEVELOPING COUNTRIES
by: A. Y. Kulikov, et al.
Published: (2015)

Syringes must be prioritized globally to ensure equitable access to COVID-19 and other essential vaccines and to sustain safe injection practices
by: Jenna Fritz, et al.
Published: (2022)

The role of pharmaceutical analysis in ensuring the safety of drug radiation sterilization
by: Magdalena Ogrodowczyk, et al.
Published: (2023)

Use of generic medicines by the Brazilian population: an evaluation of PNAUM 2014
by: Andréa Dâmaso Bertoldi, et al.

Prescrição de antimicrobianos em unidades de saúde da família no Sul do Brasil Antimicrobial prescription in family health units in Southern Brazil
by: Noemia U. L. Tavares, et al.
Published: (2008)

Access to medicines: relations with the institutionalization of pharmaceutical services
by: Rafael Damasceno de Barros, et al.
Published: (2017)

Pharmaceutical policies for gaining access to high-priced medicines: a comparative analysis between England and Brazil
by: Geison Vicente, et al.
Published: (2022)

MANAGERIAL STRATEGIES TO ENSURE ACCESS TO EDUCATION IN THE PANDEMIC CONTEXT
by: Aura ŢABĂRĂ
Published: (2022)

Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25-26 April 2024
Published: (2024)

The less healthy urban population: income-related health inequality in China
by: Yang Wei, et al.
Published: (2012)

Applying Multiple Criteria Decision Analysis (MCDA) in the context of HTA: an experimental case study on metastatic colorectal cancer
by: Aris Angelis, et al.
Published: (2015)

Using Multiple Criteria Decision Analysis (MCDA) to make coverage decisions: a methodological framework
by: Panos Kanavos, et al.
Published: (2015)

Access to medicines for chronic diseases in Brazil: a multidimensional approach
by: Maria Auxiliadora Oliveira, et al.

Free access to medicines for the treatment of chronic diseases in Brazil
by: Noemia Urruth Leão Tavares, et al.

Ensuring Pharmaceutical Product Success through Excipient QbD Efforts
by: Mohammad Siddique Qadir
Published: (2022)

A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename)
by: Helena Lutéscia L. Coelho, et al.
Published: (2013)

A critical comparison between the World Health Organization list of essential medicines for children and the Brazilian list of essential medicines (Rename)
by: Helena Lutéscia L. Coelho, et al.
Published: (2013)